Pedal the Cause—San Diego officially announced the second annual Pedal the Cause event last week at an exciting kick-off held at UCSD Moores Cancer Center. The only multi-day cycling fundraiser to support cancer research in San Diego, Pedal the Cause provides critical funding to the community’s three NCI-designated cancer centers.
The second annual bike ride features 10, 25, and 50-mile courses, as well as a two-day cycling route from La Jolla to Temecula, Calif. Virtual rider and volunteer positions are also available and offer those who choose not to ride a way to participate and support local cancer research.
As home to three NCI-designated cancer centers, San Diego has long been a powerhouse for cancer research, prevention, and treatment. Three singular institutions, Sanford-Burnham Medical Research Institute, UC San Diego Moores Cancer Center, and the Salk Institute for Biological Studies, form the novel collaboration known as the San Diego National Cancer Institute Cancer Centers Council, or C3, and work together to leverage their distinct and combined resources to accelerate innovative approaches for the treatment and prevention of cancer.
2014’s Pedal the Cause will build on the foundation established by last year’s dedicated riders by continuing to raise much-needed funding for the three institutions that make up the C3.
“Pedal the Cause plays a pivotal and collaborative role in private-sector support of cutting-edge research that will ultimately drive innovation and more rapidly and effectively transform discoveries into treatments for cancer patients,” said Garth Powis, D.Phil., director of Sanford-Burnham’s NCI-designated Cancer Center and team captain of Sanford-Burnham’s Pedal the Cause team.
From training support to finish-line celebrations, Pedal the Cause offers an unforgettable riding experience through San Diego County—and a chance for scientists, cancer activists, educators, survivors, and supporters to work together to put an end to cancer.
For more information about courses, free training, volunteer opportunities, registering, or donating, please visit sandiego.pedalthecause.org.
About Pedal the Cause
Founded in 2012, Pedal The Cause—San Diego is a California nonprofit public benefit corporation established to fund, plan, and manage an annual cycling fundraiser in which 100 percent of the proceeds stay in San Diego to benefit cancer research at the three National Cancer Institute-designated cancer centers. The hope is that research funded by Pedal The Cause will ultimately lead to a cure for cancer, and propel San Diego to the forefront of cancer cures and care. For more information, please visit pedalthecause.org, or go to facebook.com/pedalthecause and Twitter @pedalthecause.
About the C3
The mission of the C3 is to encourage interactions between the San Diego National Cancer Institute (NCI)-designated centers, with a special focus on clinical, translational, basic science, and educational activities. Each San Diego institute will share its unique capabilities and talents. Sanford-Burnham will provide access to its Chemical Library Screening Core, enabling Salk and UC San Diego to use the extensive chemical biology and drug development resources of the Prebys Center. The Prebys Center provides assay development and robust, sensitive high-throughput assays. The Center helps identify chemical compounds that lead to drug candidates that may be further developed into cancer therapies. The Salk Institute’s Cancer Center Gene Transfer, Targeting, and Therapeutics Core (GT3) will offer design, consultation, and production services for viral vectors. Viral vectors are “biological vehicles” that deliver new genes to cells to alter their function, potentially “fixing” cells that are malfunctioning. Viral vectors may be used to replace faulty genes in cancer cells, or used to boost cell functions that protect against cancer. The UC San Diego Biorepository Core will provide access to its centralized resource for patient samples and clinical information. Allowing researchers access to human samples is essential to discovering biological targets to treat cancer, translating experimental results to human disease, and for developing cancer diagnostic tests. By sharing knowledge and valuable resources, the C3 institutes are creating an era of inter-institutional support and cooperation to accelerate the prevention, diagnosis, and treatment of cancer.